Listed

Sanofi

An insider at 4 companies in coverage, as reported on Form 4. SEC CIK 1121404. Latest Form 4 filed Sep 25, 2015.

Share

Share this page

Story card, 1080 × 1920

Roles

As stated on the filings: the relationship to the company and any officer title.

CompanyRoleTransactionsFirstLatest
Latigo Biotherapeutics, Inc.LTGO10% owner42026-08-102026-08-10
Regeneron Pharmaceuticals, Inc.REGN10% owner5512010-10-132020-06-09
Fulcrum Therapeutics, Inc.FULC10% owner32019-07-222019-07-22
Alnylam Pharmaceuticals, Inc.ALNY10% owner62015-01-222017-05-31

Transactions: 564

Every transaction reported, newest first, including grants, exercises and derivative securities. Purchases and sales (codes P and S) are open-market trades. The reported price is as stated on the form.

What these mean: insiders, Form 4, transaction codes, Rule 10b5-1 plans.

DateCompanyTransactionSharesReported priceValueFiling
2015-09-23Regeneron Pharmaceuticals, Inc.10% owner Purchase20,730$537.2133$11.1mForm 4
2015-09-23Regeneron Pharmaceuticals, Inc.10% owner Purchase23,423$536.2586$12.6mForm 4
2015-09-23Regeneron Pharmaceuticals, Inc.10% owner Purchase19,042$535.2162$10.2mForm 4
2015-09-23Regeneron Pharmaceuticals, Inc.10% owner Purchase12,828$534.4185$6.9mForm 4
2015-09-23Regeneron Pharmaceuticals, Inc.10% owner Purchase5,945$533.233$3.2mForm 4
2015-09-23Regeneron Pharmaceuticals, Inc.10% owner Purchase2,544$531.9284$1.4mForm 4
2015-09-23Regeneron Pharmaceuticals, Inc.10% owner Purchase6,043$530.6769$3.2mForm 4
2015-09-23Regeneron Pharmaceuticals, Inc.10% owner Purchase8,689$530.0952$4.6mForm 4
2015-09-23Regeneron Pharmaceuticals, Inc.10% owner Purchase4,694$529.041$2.5mForm 4
2015-09-23Regeneron Pharmaceuticals, Inc.10% owner Purchase2,573$527.8528$1.4mForm 4
2015-09-23Regeneron Pharmaceuticals, Inc.10% owner Purchase3,472$526.9029$1.8mForm 4
2015-09-23Regeneron Pharmaceuticals, Inc.10% owner Purchase1,200$525.8842$631.1kForm 4
2015-09-23Regeneron Pharmaceuticals, Inc.10% owner Purchase3,211$524.4477$1.7mForm 4
2015-09-23Regeneron Pharmaceuticals, Inc.10% owner Purchase2,600$523.4327$1.4mForm 4
2015-07-27Regeneron Pharmaceuticals, Inc.10% owner Purchase253$542.2822$137.2kForm 4
2015-07-27Regeneron Pharmaceuticals, Inc.10% owner Purchase700$541.1486$378.8kForm 4
2015-07-27Regeneron Pharmaceuticals, Inc.10% owner Purchase2,503$540.2032$1.4mForm 4
2015-07-27Regeneron Pharmaceuticals, Inc.10% owner Purchase1,600$539.2194$862.8kForm 4
2015-07-27Regeneron Pharmaceuticals, Inc.10% owner Purchase948$537.8604$509.9kForm 4
2015-07-27Regeneron Pharmaceuticals, Inc.10% owner Purchase1,633$537.101$877.1kForm 4
2015-07-27Regeneron Pharmaceuticals, Inc.10% owner Purchase305$535.7123$163.4kForm 4
2015-07-27Regeneron Pharmaceuticals, Inc.10% owner Purchase700$534.3414$374.0kForm 4
2015-07-27Regeneron Pharmaceuticals, Inc.10% owner Purchase823$533.1927$438.8kForm 4
2015-07-27Regeneron Pharmaceuticals, Inc.10% owner Purchase674$532.3597$358.8kForm 4
2015-07-27Regeneron Pharmaceuticals, Inc.10% owner Purchase500$530.708$265.4kForm 4
2015-01-29Alnylam Pharmaceuticals, Inc.10% owner Purchase97,118$95.00$9.2mForm 4
2015-01-26Alnylam Pharmaceuticals, Inc.10% owner Purchase647,448$95.00$61.5mForm 4
2015-01-22Alnylam Pharmaceuticals, Inc.10% owner Purchase196,251$9,317.00$1.83bnForm 4
2015-01-22Alnylam Pharmaceuticals, Inc.10% owner Purchase196,251$93.17$18.3mForm 4/A
2014-12-24Regeneron Pharmaceuticals, Inc.10% owner Purchase20,245$399.7415$8.1mForm 4
2014-12-24Regeneron Pharmaceuticals, Inc.10% owner Purchase3,300$398.7791$1.3mForm 4
2014-12-24Regeneron Pharmaceuticals, Inc.10% owner Purchase2,067$397.5334$821.7kForm 4
2014-12-24Regeneron Pharmaceuticals, Inc.10% owner Purchase1,700$396.6641$674.3kForm 4
2014-12-24Regeneron Pharmaceuticals, Inc.10% owner Purchase890$395.5299$352.0kForm 4
2014-12-24Regeneron Pharmaceuticals, Inc.10% owner Purchase700$393.8886$275.7kForm 4
2014-12-24Regeneron Pharmaceuticals, Inc.10% owner Purchase1,100$392.7173$432.0kForm 4
2014-12-23Regeneron Pharmaceuticals, Inc.10% owner Purchase9,983$398.1565$4.0mForm 4
2014-12-23Regeneron Pharmaceuticals, Inc.10% owner Purchase16,237$397.7191$6.5mForm 4
2014-12-23Regeneron Pharmaceuticals, Inc.10% owner Purchase2,868$396.6363$1.1mForm 4
2014-12-23Regeneron Pharmaceuticals, Inc.10% owner Purchase47,730$394.8543$18.8mForm 4
2014-12-23Regeneron Pharmaceuticals, Inc.10% owner Purchase16,393$393.9927$6.5mForm 4
2014-12-23Regeneron Pharmaceuticals, Inc.10% owner Purchase8,030$392.9571$3.2mForm 4
2014-12-23Regeneron Pharmaceuticals, Inc.10% owner Purchase2,550$391.2539$997.7kForm 4
2014-12-23Regeneron Pharmaceuticals, Inc.10% owner Purchase12,046$389.8806$4.7mForm 4
2014-12-23Regeneron Pharmaceuticals, Inc.10% owner Purchase15,104$389.1733$5.9mForm 4
2014-12-23Regeneron Pharmaceuticals, Inc.10% owner Purchase5,500$388.0395$2.1mForm 4
2014-12-23Regeneron Pharmaceuticals, Inc.10% owner Purchase17,013$386.4523$6.6mForm 4
2014-12-23Regeneron Pharmaceuticals, Inc.10% owner Purchase16,813$385.5228$6.5mForm 4
2014-12-23Regeneron Pharmaceuticals, Inc.10% owner Purchase1,190$384.4259$457.5kForm 4
2014-10-16Regeneron Pharmaceuticals, Inc.10% owner Purchase9,625$339.9273$3.3mForm 4

Source: SEC EDGAR, Forms 4. Last ingested by Listed: Nov 1, 2026, 17:40 ET. Listed shows no prices and gives no investment advice.